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Abstract
Background: The association between waist circumference (WC) and mortality is particularly strong and direct when
adjusted for body mass index (BMI). One conceivable explanation for this association is that WC adjusted for BMI is a better
predictor of the presumably most harmful intra-abdominal fat mass (IAFM) than WC alone. We studied the prediction of
abdominal subcutaneous fat mass (ASFM) and IAFM by WC alone and by addition of BMI as an explanatory factor.
Methodology/Principal Findings: WC, BMI and magnetic resonance imaging data from 742 men and women who
participated in clinical studies in Canada and Finland were pooled. Total adjusted squared multiple correlation coefficients
(R
2) of ASFM and IAFM were calculated from multiple linear regression models with WC and BMI as explanatory variables.
Mean BMI and WC of the participants in the pooled sample were 30 kg/m
2 and 102 cm, respectively. WC explained 29% of
the variance in ASFM and 51% of the variance in IAFM. Addition of BMI to WC added 28% to the variance explained in ASFM,
but only 1% to the variance explained in IAFM. Results in subgroups stratified by study center, sex, age, obesity level and
type 2 diabetes status were not systematically different.
Conclusion/Significance: The prediction of IAFM by WC is not improved by addition of BMI.
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Introduction
Several studies suggest that the association between anthropo-
metric measures of obesity, such as body mass index (BMI) and
waist circumference (WC), and mortality is U-shaped [1–3].
However, recent large-scale studies have consistently shown that
the association between WC and mortality is particularly strong
and direct when adjusted for BMI [1,4–8]. The explanation
behind this direct association is not established, but one
conceivable explanation is that WC adjusted for BMI is a better
predictor than WC alone of intra-abdominal fat mass (IAFM),
which is presumed to be the most harmful fat depot [9,10].
We pooled anthropometric and magnetic resonance imaging
(MRI) data from European and American samples, and studied
the prediction of abdominal subcutaneous fat mass (ASFM) and
IAFM by WC alone and by addition of BMI as an explanatory
factor.
Materials and Methods
Subjects
Subjects (Table S1) were white men and women with no
chronic illness, except for type 2 diabetes and a small subset of
subjects with stress related angina pectoris symptoms [11].
Subjects were recruited mainly via the general media to participate
in clinical studies in Canada [12–15] and two sites of Finland;
Helsinki [16] and Turku [11,17–20] in the late 1990’s and up to
2010. Written informed consent was obtained from each
participant in accordance with the local ethical guidelines and
with the Helsinki Declaration II.
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Explanatory variables were BMI (kg/m
2) and WC (cm). In all
centres, height was measured with a height ruler, and body weight
was measured with participants wearing light clothes and no shoes.
In Canada, WC was measured at the superior edge of the iliac
crest or at the level of the lowest rib. In Helsinki, WC was
measured midway between spina iliaca superior and the lower rib
margin. In Turku, WC was measured at the level of the umbilicus.
In all centres, BMI was calculated as weight in kilograms divided
by the square of height in meters.
Outcome variables were ASFM and IAFM obtained using
MRI. In Canada, abdominal fat mass was determined using 4–5
images acquired from the region extending from 5 cm below to
15 cm above the L4 and L5 intervertebral space using the method
described previously [21]. IAFM was defined as intra-perito-
neal+retroperitoneal fat mass. In Helsinki, abdominal fat mass was
determined by a series of 16 T1-weighted transaxial images
acquired from the region extending from 8 cm above to 8 cm
below the L4 and L5 intervertebral space using the method
described previously [22]. IAFM was defined as intra-peritoneal
fat mass. In Turku, abdominal fat mass was determined from a
single 10-mm thick axial image at the level of the intervertebral
disc L2–L3 using the method described previously [23]. IAFM was
defined as intra-peritoneal fat mass, and retroperitoneal fat mass
was also assessed. In all centers, an adipose tissue density of
0.9196 g/ml was used to convert the measured volumes into kilos.
Covariates were study centre, sex, age and type 2 diabetes. Type
2 diabetes status was assed from oral glucose tolerance tests or
fasting glucose obtained according to standard protocols in the
local centers [11–20]
Heterogeneity and pooling of the data
Differences between the study centres, as partly illustrated in
Table S1, were addressed by three strategies. First, differences in
the measurements of abdominal fat masses were taken into
account by converting ASFM and IAFM into centre-specific z-
scores. Second, differences in the definitions of IAFM were taken
into account by performing the statistical analyses in three
different pooled data sets A) pooled data from Canada/Turku
using z-scores of IAFM defined as intra-peritoneal+retroperitoneal
fat mass, B) pooled data from Helsinki/Turku using z-scores of
IAFM defined as intra-peritoneal fat mass, C) pooled data from
Canada/Helsinki/Turku using z-scores of IAFM defined as intra-
peritoneal+retroperitoneal fat mass in Canada and intra-perito-
neal fat mass in Helsinki and Turku. Data from each study centre
was also analysed separately using z-scores of the centre specific
definitions of IAFM. Third, other differences, e.g. in the
measurement site of WC, were taken into account by including
centre as a covariate in analyses including all centres.
Statistical analyses
Analyses were conducted in Stata version 11.2 (Stata Corpo-
ration, College Station, Texas; www.stata.com).
The variance explained in ASFM by BMI was calculated as the
total adjusted squared multiple correlation coefficient (R
2) [24] of
ASFM obtained from a multiple linear regression model with BMI
as explanatory variable. WC was included as an explanatory
variable in a second step. Likelihood ratio tests were used to
compare the model with BMI with the model with BMI+WC.
Similar analyses were conducted for BMI and IAFM, and for WC
with BMI added in the second step. Analyses were also conducted
with study centre, sex, age and type 2 diabetes included as
explanatory factors in a third step. Furthermore, the residuals from
each of these models of BMI, WC and their combination were
plotted across the distributions of WC and BMI.
To investigate whether the associations between the anthropo-
metric measures and abdominal fat depots were equal across study
center, sex, age (cut-off at 50 years), obesity level (cut-off at BMI
$30 kg/m
2) and type 2 diabetes status (yes/no), regression
analyses were stratified according to each of these factors.
Differences between groups were tested by including cross-product
terms in the analyses.
Linearity of BMI and WC in the regression analyses was
evaluated by restricted cubic splines, and the fit of the models to
the data was found acceptable by evaluating the standardized
residuals of each model in residual and probit-plots.
Results
Table 1 provides the basic description of the participants in each
of the pooled samples.
Table 2 shows the variance explained in abdominal fat depots
by BMI, WC and their combination in each of the pooled samples.
The absolute value of R
2 varied in the samples due to differences
in sample characteristics and distribution of the explanatory
variables. BMI explained 47%, 65% and 56% of the variance in
ASFM, and 11%, 37% and 25% of the variance in IAFM in
Canada/Turku, Helsinki/Turku and Canada/Helsinki/Turku,
respectively (Table 2, crude models). Addition of WC to BMI
added 2%, 1% and 1% to the variance explained in ASFM and
40%, 17% and 27% to the variance explained in IAFM in
Canada/Turku, Helsinki/Turku and Canada/Helsinki/Turku,
respectively (Table 2, crude models). WC explained 11%, 43%
and 29% of the variance in ASFM and 49%, 54%, 51% of the
variance in IAFM in Canada/Turku, Helsinki/Turku and
Canada/Helsinki/Turku, respectively (Table 2, crude models).
Addition of BMI to WC added 38%, 23% and 28% to the
variance explained in ASFM and 2%, 0% and 1% to the variance
explained in IAFM in Canada/Turku, Helsinki/Turku and
Canada/Helsinki/Turku, respectively (Table 2, crude models).
Inclusion of study center, sex, age, and type 2 diabetes increased
the proportion of variance explained in ASFM and IAFM in all
samples (Table 2, adjusted models). As in the crude models,
addition of WC to BMI added to the variance explained in IAFM,
but only marginally to the variance explained in ASFM. Addition
of BMI to WC added to the variance explained in ASFM, but not
to the variance explained in IAFM (Table 2, adjusted models). The
residuals from the model of BMI, WC and their combination in
relation to ASFM and IAFM were similar across the distribution of
WC and BMI. So these results were in accordance with the results
based on R
2 (Figure S1 and S2)
The results stratified by study center and according to sub-
groups of sex, age, obesity level and type 2 diabetes status were not
systematically different from the results in the pooled samples
(Table S2, S3, S4, S5, S6, S7, S8, S9, S10, S11, S12, S13,S14,
crude and adjusted models).
Discussion
The present study showed, in contrast to the expectation, that
the prediction of IAFM by WC was not improved by addition of
BMI as an explanatory factor. WC explained a modest proportion
of the variation in IAFM, but the proportion was larger than the
proportion explained by BMI. Accordingly, the prediction of
IAFM by BMI was improved by addition of WC as an explanatory
factor. These results were consistent across the different pooled
samples and study centers, and in subgroups of sex, age, obesity
level and type 2 diabetes status.
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non-invasive measures of ASFM and IAFM in a large data sample.
Abdominal fat masses and WC were measured differently in the
study centres, but despite these differences, results were consistent
across the study centres. We do therefore not believe that these
measurement differences have influenced our results despite some
[25], but not other [26] studies suggesting that such measurement
differences could have an influence. Due to the large data sample,
we could address whether the results differed among sub-groups
defined according to sex, age, obesity level and type 2 diabetes
status, and results were consistent across these factors. However,
limited information on covariates was available, all participants
had the same ethnic background, and the majority was overweight
and obese. We used R
2 to assess whether WC adjusted for BMI
was a better predictor of IAFM than WC alone. R
2 is dependent
on the distribution of the explanatory variables, and, accordingly,
the absolute value of R
2 varied in the different samples. However,
the prediction of IAFM by WC was not improved by addition of
BMI as an explanatory factor in any of the samples, which suggests
that predictive value of WC and WC adjusted for BMI was not
influenced by differences in the distribution of the explanatory
variables.
Several large-scale studies have shown that the association
between WC and mortality is particularly strong and direct when
adjusted for BMI [1,4–8]. One conceivable explanation for this
association has been that WC adjusted for BMI is a better
predictor of IAFM than WC alone. The variation in WC is
believed to originate from variation in ASFM and IAFM, whereas
Table 1. Characteristics of the study participants in each of the samples pooled.
Canada/Turku (n=383) Helsinki/Turku (n=502) Canada/Helsinki/Turku (n=742)
Median (10–90%-tile) Median (10–90%-tile) Median (10–90%-tile)
Age 57 (38; 72) 48 (25.8; 64) 49 (27;68)
Body mass Index (kg/m
2) 30.6 (26.6; 35.8) 29.7 (23.5; 36.6) 30.2 (24.2; 35.9)
Waist Circumference (cm) 103.8 (91; 115.5) 101 (83.5; 118) 102.3 (86; 117.5)
Abdominal Subcutaneous Fat Mass (kg) 4.6 (2.9; 7.2) 3.9 (1.8; 6.9) 4.2 (2.1; 7.0)
Intra-Abdominal Fat Mass (kg) 3.0 (1.6; 4.8)* 1.5 (0.5; 3.2)# 1.9 (0.6; 4.1)¤
Women in the sample 46.7% (179) 49.8% (250) 50.3% (373)
Subjects with type 2 diabetes 27.1% (104) 36.7% (184) 25.9% (192)
*Intra-Abdominal Fat Mass=intra-peritoneal fat mass+retroperitoneal fat mass.
#Intra-Abdominal Fat Mass=intra-peritoneal fat mass.
¤Intra-Abdominal Fat Mass=intra-peritoneal fat mass+retroperitoneal fat mass in Canada and intra-peritoneal fat mass in Helsinki and Turku.
doi:10.1371/journal.pone.0032213.t001
Table 2. Variance explained in abdominal subcutaneous fat mass and intra-abdominal fat mass by body mass index, waist
circumference and their combination in each of the pooled samples.
Canada+Turku # Helsinki/Turku ¤ Canada/Helsinki/TurkuI
ASFM ASFM ASFM
Crude Adjusted* Crude Adjusted* Crude Adjusted*
R
2 R
2 R
2 R
2 R
2 R
2
BMI 0.47 0.60 0.65 0.76 0.56 0.70
WC 0.11 0.56 0.43 0.73 0.29 0.66
BMI+WC 0.49 0.62 0.66 0.78 0.57 0.72
IAFM IAFM IAFM
Crude Adjusted* Crude Adjusted* Crude Adjusted*
R
2 R
2 R
2 R
2 R
2 R
2
BMI 0.11 0.52 0.37 0.64 0.25 0.58
WC 0.49 0.59 0.54 0.66 0.51 0.63
BMI+WC 0.51 0.59 0.54{ 0.67 0.52 0.63
Abbreviations: ASFM, abdominal subcutaneous fat mass. BMI, body mass index- IAFM, intra-abdominal fat mass. R
2, adjusted squared multiple correlation coefficients.
WC, waist circumference.
*Regression models adjusted for study center, sex, age, type 2 diabetes status.
#Intra-abdominal fat mass=intra-peritoneal fat mass+retroperitoneal fat mass.
¤Intra-abdominal fat mass=intra-peritoneal fat mass.
IIntra-abdominal fat mass=intra-peritoneal fat mass+retroperitoneal fat mass in Canada and intra-peritoneal mass in Helsinki and Turku.
p,0.05 for WC and BMI in all models, except for BMI in { where p.0.05.
doi:10.1371/journal.pone.0032213.t002
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variation in subcutaneous fat mass, both at the abdomen and
elsewhere. By adjusting WC for BMI, the hypothesis has been that
the variation in ASFM is removed from the variation in WC,
whereby the variation left in WC adjusted for BMI may directly
reflect the variation in IAFM. Our data do not confirm this
hypothesis, as addition of BMI to WC did not add to the variance
explained in IAFM. Similar to our results, a previous study on
white men and women found that addition of BMI to WC added
to the variance explained in ASFM, but not to the variance
explained in IAFM [27]. The increased mortality risk associated
with a high WC in a model adjusted for BMI may, however, not
only reflect the effects of high amounts of (intra) abdominal fat
mass, but also the effects of low amounts of beneficial body
compartments, such as gluteofemoral fat mass or lean body mass
[28–30]. More studies of WC and WC adjusted for BMI in
relation to imaging measurements of fat distribution and body
composition are needed to understand the mechanism behind the
strong, direct and replicated association between WC adjusted for
BMI and mortality [1,4–8].
In conclusion, our results do not support the hypothesis that
WC adjusted for BMI is a better predictor of IAFM than WC
alone. Therefore, the assumption that WC adjusted for BMI is a
better predictor of IAFM than WC alone should be reconsidered.
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Turku sample. Abbreviations: ASFM, abdominal subcutaneous
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upper panel are derived from a model with WC (left) or BMI
(right) as explanatory variables. The residuals in the lower panel
are derived from a model with WC and BMI as explanatory
variables.
(TIF)
Figure S2 The association between waist circumfer-
ence, body mass index and the residuals of intra-
abdominal fat mass in the pooled Canada/Helsinki/
Turku sample. Abbreviations: BMI, body mass index. CAN,
Canada. HEL, Helsinki. IAFM, intra-abdominal fat mass. TUR,
Turku. WC, waist circumference. Intra-abdominal fat mass=in-
tra-peritoneal fat mass+retroperitoneal fat mass in Canada and
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(right) as explanatory variables. The residuals in the lower panel
are derived from a model with WC and BMI as explanatory
variables.
(TIF)
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